Risk of Ventricular Arrhythmia After Implantable Defibrillator Treatment in Anxious Type D Patients

Journal of the American College of Cardiology

Volumn 54, Issue 6, 2009, Pages 531-537

  van den Broek, Krista C ^a   Nyklíček, Ivan ^a   van der Voort, Pepijn H ^b   Alings, Marco ^c   Meijer, Albert ^b   Denollet, Johan ^a  

^a TILBURG UNIVERSITY   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

Author keywords

anxiety; depression; implantable defibrillator; Type D personality; ventricular arrhythmias

Indexed keywords

ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DEPRESSION; DISTRESS SYNDROME; FEMALE; HAZARD RATIO; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FUNCTION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PERSONALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SECONDARY PREVENTION; SEX; SYMPTOM; TYPE D PERSONALITY;

AGED; ANXIETY DISORDERS; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY; RISK FACTORS;

EID: 67651121723     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.04.043     Document Type: Article

References (59)

1. Huikuri H.V., Castellanos A., and Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 345 (2001) 1473-1482
2. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48 (2006) e247-e346
3. Ezekowitz J.A., Armstrong P.W., and McAlister F.A. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 138 (2003) 445-452
4. Glikson M., and Friedman P.A. The implantable cardioverter defibrillator. Lancet 357 (2001) 1107-1117
5. Glass L., and Lerma C. Risk stratification for arrhythmic sudden cardiac death. Heart Rhythm 3 (2006) 1497-1501
6. Anderson K.P. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interv Card Electrophysiol 14 (2005) 71-78
7. Whang W., Mittleman M.A., Rich D.Q., et al. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study. Circulation 109 (2004) 1386-1391
8. Desai A.D., Burke M.C., Hong T.E., et al. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy. J Cardiovasc Electrophysiol 17 (2006) 486-490
9. Klein G., Lissel C., Fuchs A.C., et al. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study. Europace 8 (2006) 618-624
10. Pedersen S.S., and van den Broek K.C. ICD shocks and their adverse impact on patient-centered outcomes: fact or fiction?. J Am Coll Cardiol 52 (2008) 1037-1038
11. Bilge A.K., Ozben B., Demircan S., Cinar M., Yilmaz E., and Adalet K. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 29 (2006) 619-626
12. Pedersen S.S., Theuns D.A., Erdman R.A., and Jordaens L. Clustering of device-related concerns and Type D personality predicts increased distress in ICD patients independent of shocks. Pacing Clin Electrophysiol 31 (2008) 20-27
13. van den Broek K.C., Nyklicek I., van der Voort P.H., Alings M., and Denollet J. Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing Clin Electrophysiol 31 (2008) 850-857
14. van den Broek K.C., Nyklicek I., and Denollet J. Anxiety predicts poor perceived health in patients with an implantable defibrillator. Psychosomatics (2009) In press
15. Dougherty C.M. Psychological reactions and family adjustment in shock versus no shock groups after implantation of internal cardioverter defibrillator. Heart Lung 24 (1995) 281-291
16. Schron E.B., Exner D.V., Yao Q., et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105 (2002) 589-594
17. Pedersen S.S., Theuns D.A., Muskens-Heemskerk A., Erdman R.A., and Jordaens L. Type D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation. Europace 9 (2007) 675-680
18. Crossmann A., Pauli P., Dengler W., Kuhlkamp V., and Wiedemann G. Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: a longitudinal two-year follow-up. Heart Lung 36 (2007) 87-95
19. Pedersen S.S., van Domburg R.T., Theuns D.A., Jordaens L., and Erdman R.A. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J 149 (2005) 664-669
20. Whang W., Albert C.M., Sears Jr. S.F., et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 45 (2005) 1090-1095
21. Dunbar S.B., Kimble L.P., Jenkins L.S., et al. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 9 (1999) 163-168
22. Lampert R., Joska T., Burg M.M., Batsford W.P., McPherson C.A., and Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation 106 (2002) 1800-1805
23. Burg M.M., Lampert R., Joska T., Batsford W., and Jain D. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom Med 66 (2004) 898-902
24. Denollet J., and Pedersen S.S. Anger, depression, and anxiety in cardiac patients: the complexity of individual differences in psychological risk. J Am Coll Cardiol 53 (2009) 947-949
25. Rozanski A., Blumenthal J.A., Davidson K.W., Saab P.G., and Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 45 (2005) 637-651
26. Denollet J. Biobehavioral research on coronary heart disease: where is the person?. J Behav Med 16 (1993) 115-141
27. Pedersen S.S., Denollet J., van Gestel Y.R., Serruys P.W., and van Domburg R.T. Clustering of psychosocial risk factors enhances the risk of depressive symptoms 12-months post percutaneous coronary intervention. Eur J Cardiovasc Prev Rehabil 15 (2008) 203-209
28. In: Beck A.T., and Steer R.A. (Eds). Manual for the Revised Beck Depression Inventory (1993), Psychological Corporation, San Antonio, TX
29. Strik J.J., Honig A., Lousberg R., and Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 42 (2001) 423-428
30. Van der Ploeg H.M., Defares P.B., and Spielberger C.D. Manual for the ZBV. A Dutch-Language Adaptation of the Spielberger State-Trait Anxiety Inventory [in Dutch] (1980), Swets & Zeitlinger, B.V, Lisse, the Netherlands
31. Kamphuis H.C., de Leeuw J.R., Derksen R., Hauer R.N., and Winnubst J.A. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace 5 (2003) 381-389
32. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and type D personality. Psychosom Med 67 (2005) 89-97
33. Emons W.H., Meijer R.R., and Denollet J. Negative affectivity and social inhibition in cardiovascular disease: evaluating type D personality and its assessment using item response theory. J Psychosom Res 63 (2007) 27-39
34. Martens E.J., Kupper N., Pedersen S.S., Aquarius A.E., and Denollet J. Type D personality is a stable taxonomy in post-MI patients over an 18-month period. J Psychosom Res 63 (2007) 545-550
35. De Jonge P., Denollet J., Van Melle J.P., et al. Associations of type D personality and depression with somatic health in myocardial infarction patients. J Psychosom Res 63 (2007) 477-482
36. Denollet J., Vaes J., and Brutsaert D.L. Inadequate response to treatment in coronary heart disease: adverse effects of type D personality and younger age on 5-year prognosis and quality of life. Circulation 102 (2000) 630-635
37. Pedersen S.S., Lemos P.A., van Vooren P.R., et al. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy. J Am Coll Cardiol 44 (2004) 997-1001
38. Denollet J., Sys S.U., Stroobant N., Rombouts H., Gillebert T.C., and Brutsaert D.L. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 347 (1996) 417-421
39. Denollet J., and Brutsaert D.L. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 97 (1998) 167-173
40. Pedersen S.S., and Denollet J. Is type D personality here to stay?. Emerging evidence across cardiovascular disease patient groups. Curr Cardiol Rev 2 (2006) 205-213
41. Field A. Discovering Statistics Using SPSS. 2nd edition (2005), SAGE Publications, London
42. Denollet J., Martens E.J., Nyklicek I., Conraads V.M., and de Gelder B. Clinical events in coronary patients who report low distress: adverse effect of repressive coping. Health Psychol 27 (2008) 302-308
43. Denollet J., Strik J.J., Lousberg R., and Honig A. Recognizing increased risk of depressive comorbidity after myocardial infarction: looking for 4 symptoms of anxiety-depression. Psychother Psychosom 75 (2006) 346-352
44. Denollet J., Pedersen S.S., Ong A.T., Erdman R.A., Serruys P.W., and van Domburg R.T. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era. Eur Heart J 27 (2006) 171-177
45. Denollet J. Type D personality. A potential risk factor refined. J Psychosom Res 49 (2000) 255-266
46. Pedersen S.S., Denollet J., Spindler H., et al. Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention. J Psychosom Res 61 (2006) 783-789
47. Ladwig K.H., Baumert J., Marten-Mittag B., Kolb C., Zrenner B., and Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry 65 (2008) 1324-1330
48. Anderson K.P. Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances. Ann Noninvasive Electrocardiol 8 (2003) 75-89
49. Podrid P.J., Fuchs T., and Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 82 (1990) I103-I113
50. Kop W.J., Krantz D.S., Nearing B.D., et al. Effects of acute mental stress and exercise on T-wave alternans in patients with implantable cardioverter defibrillators and controls. Circulation 109 (2004) 1864-1869
51. Gold M.R., Bloomfield D.M., Anderson K.P., et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 36 (2000) 2247-2253
52. Lampert R., Jain D., Burg M.M., Batsford W.P., and McPherson C.A. Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverter-defibrillators. Circulation 101 (2000) 158-164
53. Sweeney M.O., Wathen M.S., Volosin K., et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 111 (2005) 2898-2905
54. Hreybe H., and Saba S. A clinical risk score to predict the time to first appropriate device therapy in recipients of implantable cardioverter defibrillators. Pacing Clin Electrophysiol 30 (2007) 385-389
55. Watkins L.L., Blumenthal J.A., Davidson J.R., Babyak M.A., McCants Jr. C.B., and Sketch Jr. M.H. Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. Psychosom Med 68 (2006) 651-656
56. McMurray J., Kober L., Robertson M., et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol 45 (2005) 525-530
57. Ladwig K.H., Deisenhofer I., Simon H., Schmitt C., and Baumert J.J. Characteristics associated with low treatment satisfaction in patients with implanted cardioverter defibrillators: results from the LICAD study. Pacing Clin Electrophysiol 28 (2005) 506-513
58. Baumert J., Schmitt C., and Ladwig K.H. Psychophysiologic and affective parameters associated with pain intensity of cardiac cardioverter defibrillator shock discharges. Psychosom Med 68 (2006) 591-597
59. Pedersen S.S., van den Broek K.C., and Sears Jr. S.E. Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations. Pacing Clin Electrophysiol 30 (2007) 1546-1554